PENICILLAMINE
Generic: PENICILLAMINE
Actavis PharmaManufacturer
ORALRoute
PENICILLAMINEActive Substance
2019-06-24Original Approval
PENICILLAMINE is FDA application ANDA210976, sponsored by WATSON LABS INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
DRUG HYPERSENSITIVITY
177 reports
2
DRUG INEFFECTIVE
167 reports
3
ARTHRALGIA
148 reports
4
JOINT SWELLING
141 reports
5
INFLAMMATION
111 reports
6
DIARRHOEA
87 reports
7
NAUSEA
85 reports
8
HYPERSENSITIVITY
79 reports
9
DRUG INTOLERANCE
78 reports
10
ANAPHYLACTIC REACTION
77 reports